Tradewinds Capital Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-97
| Closed | -$3.76K | – | 668 |
|
|
2025
Q1 | $3.76K | Hold |
97
| – | – | ﹤0.01% | 440 |
|
|
2024
Q4 | $3.28K | Hold |
97
| – | – | ﹤0.01% | 465 |
|
|
2024
Q3 | $3.97K | Hold |
97
| – | – | ﹤0.01% | 420 |
|
|
2024
Q2 | $3.73K | Hold |
97
| – | – | ﹤0.01% | 407 |
|
|
2024
Q1 | $4.16K | Hold |
97
| – | – | ﹤0.01% | 374 |
|
|
2023
Q4 | $3.6K | Hold |
97
| – | – | ﹤0.01% | 313 |
|
|
2023
Q3 | $3.52K | Hold |
97
| – | – | ﹤0.01% | 306 |
|
|
2023
Q2 | $3.46K | Hold |
97
| – | – | ﹤0.01% | 302 |
|
|
2023
Q1 | $3.45K | Hold |
97
| – | – | ﹤0.01% | 305 |
|
|
2022
Q4 | $3.41K | Hold |
97
| – | – | ﹤0.01% | 319 |
|
|
2022
Q3 | $3K | Sell |
97
-1
| -1% | -$38 | ﹤0.01% | 303 |
|
|
2022
Q2 | $5K | Buy |
+98
| New | +$5.41K | ﹤0.01% | 271 |
|
|
2019
Q1 | – | Sell |
-160
| Closed | -$8K | – | 616 |
|
|
2018
Q4 | $8K | Hold |
160
| – | – | ﹤0.01% | 413 |
|
|
2018
Q3 | $8K | Hold |
160
| – | – | ﹤0.01% | 437 |
|
|
2018
Q2 | $8K | Hold |
160
| – | – | ﹤0.01% | 434 |
|
|
2018
Q1 | $8K | Hold |
160
| – | – | ﹤0.01% | 426 |
|
|
2017
Q4 | $7K | Hold |
160
| – | – | ﹤0.01% | 460 |
|
|
2017
Q3 | $8K | Hold |
160
| – | – | ﹤0.01% | 425 |
|
|
2017
Q2 | $9K | Buy |
+160
| New | +$8.53K | ﹤0.01% | 411 |
|
|
2016
Q4 | – | Sell |
-240
| Closed | -$13K | – | 661 |
|
|
2016
Q3 | $13K | Hold |
240
| – | – | 0.01% | 346 |
|
|
2016
Q2 | $13K | Hold |
240
| – | – | 0.01% | 344 |
|
|
2016
Q1 | $12K | Sell |
240
-72
| -23% | -$3.59K | 0.01% | 376 |
|
|
2015
Q4 | $16K | Buy |
312
+240
| +333% | +$12.2K | 0.01% | 326 |
|
|
2015
Q3 | $3K | Hold |
72
| – | – | ﹤0.01% | 485 |
|
|
2015
Q2 | $4K | Hold |
72
| – | – | ﹤0.01% | 495 |
|
|
2015
Q1 | $4K | Sell |
72
-160
| -69% | -$9.17K | ﹤0.01% | 461 |
|
|
2014
Q4 | $12K | Sell |
232
-161
| -41% | -$9.01K | 0.01% | 357 |
|
|
2014
Q3 | $23K | Buy |
393
+160
| +69% | +$9.81K | 0.02% | 283 |
|
|
2014
Q2 | $16K | Hold |
233
| – | – | 0.01% | 326 |
|
|
2014
Q1 | $16K | Hold |
233
| – | – | 0.01% | 336 |
|
|
2013
Q4 | $16K | Buy |
+233
| New | +$15.1K | 0.01% | 323 |
|
Other funds holding GSK
JEST
Tradewinds Capital Management's GSK Position: Q2 2025 in Review
Tradewinds Capital Management sold out of GSK (GSK) in Q2 2025, closing a stake of 97 shares — an estimated $3.76K sold.
Tradewinds Capital Management first reported a position in GSK in Q4 2013 and held it in 31 quarters. The position peaked at $23K in Q3 2014. 890 funds tracked by Wall St. Rank hold GSK as of Q2 2025.
- Tradewinds Capital Management reported no remaining GSK position as of Q2 2025 after selling out during the quarter.
- Tradewinds Capital Management sold 97 GSK shares in Q2 2025, an estimated $3.76K.
- Tradewinds Capital Management first reported a position in GSK in Q4 2013 and held it in 31 quarters.
- Tradewinds Capital Management's GSK position peaked at $23K in Q3 2014.
- 890 funds tracked by Wall St. Rank held GSK as of Q2 2025.
Based on Tradewinds Capital Management's 13F filing for Q2 2025, filed 29 Jul 2025.